PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 44.15
+0.05 (0.11%)
Oct 22, 2026, 5:30 PM CEST
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.46 billion as of October 22, 2026. It is the 7,183rd most valuable company in the world and the 100th biggest in Switzerland. Its market cap has increased by 83.71% in one year.
Market Cap
1.46B
Enterprise Value
1.54B
Revenue
423.58M
Global Rank
Country Rank
#100 Switzerland
PE Ratio
107.97
ChartMarket Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.46B, a decrease of -43.73%. That is a compound annual growth rate of -9.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 1.46B | 69.29% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 308.95B |
| Novartis AG | 238.77B |
| Lonza Group AG | 43.25B |
| Galderma Group AG | 40.80B |
| Medacta Group | 2.29B |
| SKAN Group AG | 1.64B |
| Aevis Victoria | 1.22B |
| Idorsia | 1.12B |